The stocks most likely to witness significant movement on the bourses are Natco Pharma, Hindustan Aeronautics, Reliance Industries, Amara Raja and Indian Bank.

Indian Cements reported its results for the quarter ended September 30, 2018. The company's standalone revenue for the quarter Q2FY19 came in at Rs. 1,387.05 crore as against Rs. 1,268.26 crore in the corresponding quarter last year, registering 9.4 per cent YoY increase.

Gold once considered as the most prized asset of retail investors is losing its sheen and equity MF is emerging as the preferred investment vehicle.

Following stocks are close to their 52-week low as at 12.37 p.m. on November 9, 2018.

The markets on November 9, 2018 opened positive. BSE Sensex is trading at 35,210.50, Down by 27.18 points and the Nifty is trading at 10,600.10, up by 1.70 points. 

Strides Pharma’s wholly-owned subsidiary, Strides Pharma Global Pte Limited, Singapore signed a partnership agreement with SUDA Pharmaceuticals Limited for the exclusive product development, licensing and supply of sumatriptan in the US market.

The company has received a Letter of award (LoA) for upgrading, two laning of roads with pavement shoulder from PWD department of Maharashtra state.

Overall volumes in futures & options currently stand at 14, 20,610 contracts with a turnover of Rs. 74,455.46.

Overall volumes in futures & options currently stand at 14, 20,610 contracts with a turnover of Rs. 74,455.46.

The company's wholly-owned subsidiary acquired Stelligent Systems, LLC for a consideration of US$ 25 million on Thursday.